Bird Flu’s Human Risk Spurs Phage Therapy Research
Исследования по терапии фагами спровоцированы риском для человека.
Engineering bacteriophages as precision treatments and vaccine vectors.
Engineering bacteriophages as precision treatments and vaccine vectorsBy Kathy Liszewski
Bacteriophages can precisely target and destroy harmful pathogenic bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa.
Scientists at Armata Pharmaceuticals utilize tools such as synthetic biology to engineer therapeutic improvements into both phages and manufacturing hosts.
Highly pathogenic avian influenza A (H5N1, commonly known as HPAI or bird flu) is a formidable worldwide public health concern.
With approximately a 100% mortality rate, the World Organization for Animal Health estimates that more than 633 million birds (poultry and wild birds) have been lost globally over the past 20 years.
Author's summary: Bird flu sparks research.
More News
- GRIDLOCK Definition & Meaning
- Cheap Domestic Flights in United States of America
- Women’s Big Bash League 2025-26 results
- Benin Rejects Claims of a Coup by Opposition Soldiers
- Tartan Army set for ‘big bash’ in Boston with two games in New England
- Sydney Sixers Vs Adelaide Strikers, WBBL 2025: SYS-W Beat AS-W By One Run Thanks To Ellyse Perry Century
- Heavy rain gridlocks KL traffic
- Hundreds stranded after IndiGo canceled 1,000 flights in India air travel chaos
- Babar Azam, Mohammad Rizwan in focus: PCB clears Big Bash NOCs for Pakistan players, but with a catch
- PREDICTED TEAM: How Scorchers will line up for BBL opener